Related Experiment Video

Updated: Jul 4, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Antibodies and hematologic malignancies

Mitchell R Smith1

  • 1Lymphoma Service, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA. M_smith@fccc.edu

Cancer Journal (Sudbury, Mass.)
|June 10, 2008
PubMed

Insights

Monoclonal antibody therapy has revolutionized hematologic malignancy treatment. Future advances depend on optimizing current therapies and understanding new agents

Area of Science:

  • Hematology
  • Oncology
  • Immunotherapy

Background:

  • Monoclonal antibody therapy has significantly advanced hematologic malignancy treatment over the past decade.
  • Continued progress requires optimizing existing therapies and developing novel agents.

Purpose of the Study:

  • To review current data on monoclonal antibody therapy for hematologic malignancies.
  • To discuss new agents under investigation.
  • To identify areas needing further research in mechanisms of action and resistance.

Main Methods:

  • Literature review of existing data.
  • Analysis of ongoing clinical trials for new agents.
  • Synthesis of current understanding of treatment mechanisms and resistance pathways.

Main Results:

  • Monoclonal antibodies are a cornerstone in treating various blood cancers.
  • Several new monoclonal antibody agents are in development.
  • Understanding resistance mechanisms is crucial for improving patient outcomes.

Conclusions:

  • Optimizing current monoclonal antibody treatments is essential.
  • Further research into novel agents and resistance mechanisms will drive future therapeutic advances in hematologic malignancies.

More Related Videos

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

Related Concept Videos

Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...